Victoza liraglutide
With our client oriented approaches, we are able to provide high-quality Victoza Liraglutide.
Specifications :
-
Initial Dose : 0.6 mg subcutaneously once a day for 1 week; this dose is intended to reduce gastrointestinal symptoms and is not an effective dose for glycemic control
-
Maintenance dose : Inject 1.2 mg subcutaneously once a day; if acceptable glycemic control is not achieved, may increase to 1.8 mg subcutaneously once a day
-
Maximum Dose : 1.8 mg once a day
|